SLC12A6

Chr 15ARAD

solute carrier family 12 member 6

Also known as: ACCPN, CMT2II, KCC3, KCC3A, KCC3B

This gene is a member of the K-Cl cotransporter (KCC) family. K-Cl cotransporters are integral membrane proteins that lower intracellular chloride concentrations below the electrochemical equilibrium potential. The proteins encoded by this gene are activated by cell swelling induced by hypotonic conditions. Alternate splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are associated with agenesis of the corpus callosum with peripheral neuropathy. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAR/ADLOEUF 0.402 OMIM phenotypes
Clinical SummarySLC12A6
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.26) despite low pLI — interpret in context.
📋
ClinVar Variants
242 unique Pathogenic / Likely Pathogenic· 599 VUS of 1804 total submissions
📖
GeneReview available — SLC12A6
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.40LOEUF
pLI 0.011
Z-score 5.49
OE 0.26 (0.180.40)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.96Z-score
OE missense 0.67 (0.620.73)
436 obs / 648.0 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.26 (0.180.40)
00.351.4
Missense OE?0.67 (0.620.73)
00.61.4
Synonymous OE?0.99
01.21.6
LoF obs/exp: 17 / 64.6Missense obs/exp: 436 / 648.0Syn Z: 0.08
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSLC12A6-related agenesis of the corpus callosum with peripheral neuropathyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7327th %ile
GOF
0.82top 10%
LOF
0.2386th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Literature Evidence

DNOur findings expand the genotypic and phenotypic spectrum associated with SLC12A6 mutations from AR-HMSN/ACC to AD-CMT. The differences in the inheritance pattern might be associated with a dominant-negative pathomechanism.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 33323309

ClinVar Variant Classifications

1804 submitted variants in ClinVar

Classification Summary

Pathogenic68
Likely Pathogenic174
VUS599
Likely Benign821
Benign96
Conflicting32
68
Pathogenic
174
Likely Pathogenic
599
VUS
821
Likely Benign
96
Benign
32
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
59
4
5
0
68
Likely Pathogenic
167
5
2
0
174
VUS
8
469
94
28
599
Likely Benign
4
5
363
449
821
Benign
0
1
86
9
96
Conflicting
32
Total2384845504861,790

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

21 pathogenic / likely-pathogenic (of 36) ClinVar copy-number / structural variants overlap SLC12A6 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SLC12A6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →